Patents by Inventor John Langenheim

John Langenheim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTAGONIST FUSION POLYPEPTIDES
    Publication number: 20240409583
    Abstract: The present disclosure provides antagonist fusion polypeptides (e.g., with extended half-life, improved antagonist activity) comprising (i) a serum albumin binding polypeptide; (ii) a polypeptide hormone analog capable of antagonizing its receptor activation; and (iii) a linker, as well as various related technologies including, methods of producing and using such fusion polypeptides.
    Type: Application
    Filed: May 21, 2024
    Publication date: December 12, 2024
    Applicant: Kaida Biopharmaceuticals, Inc.
    Inventors: John Langenheim, Stephen Dunn